健康元：健康元药业集团股份有限公司2022年半年度报告（英文版）.PDF

1、lnterim Report 2022为明天 为健康Joincare Pharmaceutical Group Industry Co.,Ltd.FOR THE HEALTH FOR THE FUTUREStock abbreviation:健康元Stock code:600380【Mission】For the health,For the future【Vision】Attentively Develop High-quality Medicines and lnnovative Medicines【Core Values】Putting People at the first place

2、,Valuing Workmanship and Quality,Pursuing Innovation and lntegrity,Promoting Cooperation and SharingI The Board of Directors(the“Board”),the Board of Supervisors and directors,supervisors and senior management of the Company hereby warrant the truthfulness,accuracy and completeness of the contents o

3、f the interim report(the“Report”),and that there are no false representations,misleading statements or material omissions contained in the Report,and severally and jointly accept responsibility.II All the directors of the Company attended the Board meeting.III The interim report of the Company is un

4、audited.IV Mr.Zhu Baoguo(朱保国),the person-in-charge of the Company,and Mr.Qiu Qingfeng(邱庆丰),the person-in-charge of the Companys accounting work and the person-in-charge of the accounting department(the head of the accounting department),declare that they hereby warrant the truthfulness,accuracy and

5、completeness of the financial statements contained in the Report.V Profit distribution plan or plan for conversion of capital reserve to share capital approved by the Board during the Reporting PeriodNot applicableVI Risk declaration for the forward-looking statements Applicable N/AThe Report contai

6、ns forward-looking statements which involve the future plans,development strategies,etc.of the Company,yet do not constitute substantive undertakings of the Company to investors.Investors should exercise caution prior to making investment decisions.VII Whether there is non-operating use of funds by